Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Morgan Stanley Downgrades SEI Investments to Underweight

Morgan Stanley Downgrades SEI Investments to Underweight

Morgan Stanley analyst Ryan Kenny downgrades SEI Investments (NASDAQ:SEIC) from Equal-Weight to Underweight.

byBenzinga Newsdesk

July 12, 2022

1 minute read

Morgan Stanley analyst Ryan Kenny downgrades SEI Investments (NASDAQ:SEIC) from Equal-Weight to Underweight.

News

Reuters Reported Late Wednesday, Lockheed Martin, Boeing, Raytheon, Textron in Talks to Sell Helicopters, Drones to Vietnam

By Charles Gross

December 15, 6:10 AM

https://www.reuters.com/article/usa-vietnam-defence/exclusive-u-s-defence-companies-in-talks-to-sell-vietnam-helicopters-drones-sources-idINL8N3320FZ

Summit Insights Group Upgrades Silicon Laboratories to Buy

By Benzinga Newsdesk

February 2, 6:02 AM

Summit Insights Group analyst Kinngai Chan upgrades Silicon Laboratories (NASDAQ:SLAB) from Hold to Buy.

SLAB

Piper Sandler Maintains Neutral on Aurora Cannabis, Lowers Price Target to $3

By Benzinga Newsdesk

September 21, 6:38 AM

Piper Sandler analyst Michael Lavery maintains Aurora Cannabis (NASDAQ:ACB) with a Neutral and lowers the price target from $4 to $3.

ACB

Takeda Pharmaceutical Q3 Core EPS ¥168.00 Up From ¥119.00 YoY, Sales ¥1.10T Up From ¥901.30B YoY

By Benzinga Newsdesk

February 2, 4:35 AM

Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of ¥168.00 per share. This is a 41.18 percent increase over earnings of ¥119.00 per share from the same period last year. The company reported

TAK

Morgan Stanley Downgrades SEI Investments to Underweight

Related Posts

Reuters Reported Late Wednesday, Lockheed Martin, Boeing, Raytheon, Textron in Talks to Sell Helicopters, Drones to Vietnam

Summit Insights Group Upgrades Silicon Laboratories to Buy

Piper Sandler Maintains Neutral on Aurora Cannabis, Lowers Price Target to $3

Takeda Pharmaceutical Q3 Core EPS ¥168.00 Up From ¥119.00 YoY, Sales ¥1.10T Up From ¥901.30B YoY